Demographic data | |
Agea (year) | 79.6 ± 4.3 (72–87) |
Femaleb n (%) | 15 (42.9) |
BMIa (kg/m2) | 22.9 ± 3.72 |
Body surface areaa (m2) | 1.68 ± 0.18 |
Heart ratea (beats/min) | 69.1 ± 10.8 |
Systolic BPa (mmHg±SD) | 134.5 ± 2.9 |
Diastolic BPa (mmHg±SD) | 65.7 ± 11.5 |
Hemoglobina (g/L ± SD) | 114.6 ± 11.3 |
Creatininea (mmol/L ± SD) | 81.5 ± 21.3 |
STS scorea (%mortality±SD) | 8.8 ± 4.2 |
EuroSCOREa | 3.6 ± 1.9 |
Artificial aortic valveb n (%) | |
Medtronic Hancock II | 1(2.9) |
VENUS-A | 23 (65.7) |
J-Valve | 11 (31.4) |
Medical historyb n (%) | |
Hypertension | 17 (48.6) |
Diabetes | 9(25.7) |
Coronary heart disease (CHD) | 14 (40) |
Previous PCI | 3 (8.5) |
COPD | 6 (17.1) |
Degree of mitral regurgitationb n (%) | |
None/Mild | 22 (62.9)/13 (37.1) |
Mitral annular calcification n (%) | 17 (48.6) |
NYHA functional classificationb n (%) | |
I/II/III/IV | 0/8 (22.9)/24 (68.6)/3 (8.5) |
Diastolic dysfunctionb n (%) | |
Normal/I/II/ III/Indeterminate | 7 (20)/7 (20)/14 (40)/5 (14)/2 (6) |